NCT04082039View on ClinicalTrials.gov

Two-channel Intravenous Patient-controlled Analgesia (IV-PCA) After Total Laparoscopic Hysterectomy (TLH)

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 3, 2019

Primary Completion Date

August 10, 2020

Study Completion Date

October 30, 2020

Conditions
Total Laparoscopic HysterectomyPatient-controlled Analgesia
Interventions
OTHER

convetional PCA method unsing only 1-channel

Ch-1 (flow 2 ml/hr with bolus 2ml/30min lock-out): fentanyl 16 µg/kg, ketorolac 2 mg/kg, ondansetron 12 mg (total volume 100 ml with normal saline); Ch-2 (flow 2ml/h): 100ml normal saline only (for blinding)

OTHER

utilizing 2-channel

Ch-1 (flow 2 ml/hr with bolus 2ml/30min lock-out): fentanyl 16 µg/kg (total volume 100 ml with normal saline; Ch-2 (flow 2ml/h fixed): ketorolac 2 mg/kg, ondansetron 12 mg (total volume 100 ml with normal saline)

Trial Locations (1)

08308

Department of Anaesthesiology and Pain Medicine, Korea University Guro Hospital, Seoul

All Listed Sponsors
lead

Korea University Guro Hospital

OTHER

NCT04082039 - Two-channel Intravenous Patient-controlled Analgesia (IV-PCA) After Total Laparoscopic Hysterectomy (TLH) | Biotech Hunter | Biotech Hunter